skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Results 1 - 20 of 5,381  for All Library Resources

Results 1 2 3 4 5 next page
Show only
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Composition and divergence of coronavirus spike proteins and host ACE2 receptors predict potential intermediate hosts of SARS‐CoV‐2
Material Type:
Article
Add to My Research

Composition and divergence of coronavirus spike proteins and host ACE2 receptors predict potential intermediate hosts of SARS‐CoV‐2

Journal of Medical Virology, 2020-06, Vol.92 (6) [Peer Reviewed Journal]

2020. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://novel-coronavirus.onlinelibrary.wiley.com ;DOI: 10.1002/jmv.25726

Digital Resources/Online E-Resources

2
Antibody Responses in Seropositive Persons after a Single Dose of SARS-CoV-2 mRNA Vaccine
Material Type:
Article
Add to My Research

Antibody Responses in Seropositive Persons after a Single Dose of SARS-CoV-2 mRNA Vaccine

New England Journal of Medicine, 2021-04, Vol.384 (14), p.1372-1374 [Peer Reviewed Journal]

Copyright © 2021 Massachusetts Medical Society. All rights reserved. ;2021. Not withstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://www.nejm.org/about-nejm/permissions?query=footer ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMc2101667

Digital Resources/Online E-Resources

3
N501Y mutation of spike protein in SARS-CoV-2 strengthens its binding to receptor ACE2
Material Type:
Article
Add to My Research

N501Y mutation of spike protein in SARS-CoV-2 strengthens its binding to receptor ACE2

eLife, 2021-08, Vol.10 [Peer Reviewed Journal]

2021, Tian et al. ;2021, Tian et al. This work is published under https://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2021, Tian et al 2021 Tian et al ;ISSN: 2050-084X ;EISSN: 2050-084X ;DOI: 10.7554/elife.69091 ;PMID: 34414884

Full text available

4
SARS-CoV-2 spike protein interacts with and activates TLR41
Material Type:
Article
Add to My Research

SARS-CoV-2 spike protein interacts with and activates TLR41

Cell research, 2021-07, Vol.31 (7), p.818-820 [Peer Reviewed Journal]

The Author(s), under exclusive licence to Center for Excellence in Molecular Cell Science, CAS 2021. ;The Author(s), under exclusive licence to Center for Excellence in Molecular Cell Science, CAS 2021 ;ISSN: 1001-0602 ;EISSN: 1748-7838 ;DOI: 10.1038/s41422-021-00495-9 ;PMID: 33742149

Full text available

5
SARS-CoV-2 Spike Protein Induces Paracrine Senescence and Leukocyte Adhesion in Endothelial Cells
Material Type:
Article
Add to My Research

SARS-CoV-2 Spike Protein Induces Paracrine Senescence and Leukocyte Adhesion in Endothelial Cells

Journal of virology, 2021-08, Vol.95 (17), p.e0079421-e0079421 [Peer Reviewed Journal]

Copyright © 2021 American Society for Microbiology. ;Copyright © 2021 American Society for Microbiology. 2021 American Society for Microbiology ;ISSN: 0022-538X ;EISSN: 1098-5514 ;DOI: 10.1128/JVI.00794-21 ;PMID: 34160250

Full text available

6
Rapid Generation of Neutralizing Antibody Responses in COVID-19 Patients
Material Type:
Article
Add to My Research

Rapid Generation of Neutralizing Antibody Responses in COVID-19 Patients

Cell Reports Medicine, 2020-06, Vol.1 (3), p.100040-100040, Article 100040 [Peer Reviewed Journal]

2020 The Author(s) ;2020 The Author(s). ;2020. Not withstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://www.elsevier.com/legal/elsevier-website-terms-and-conditions ;2020 The Author(s) 2020 ;ISSN: 2666-3791 ;EISSN: 2666-3791 ;DOI: 10.1016/j.xcrm.2020.100040 ;PMID: 32835303

Digital Resources/Online E-Resources

7
Covid-19: Omicron may be more transmissible than other variants and partly resistant to existing vaccines, scientists fear
Material Type:
Article
Add to My Research

Covid-19: Omicron may be more transmissible than other variants and partly resistant to existing vaccines, scientists fear

BMJ (Online), 2021-11, Vol.375, p.n2943-n2943 [Peer Reviewed Journal]

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to ;This article is made freely available for use in accordance with BMJ's website terms and conditions for the duration of the covid-19 pandemic or until otherwise determined by BMJ. You may use, download and print the article for any lawful, non-commercial purpose (including text and data mining) provided that all copyright notices and trade marks are retained. https://bmj.com/coronavirus/usage? ;ISSN: 1756-1833 ;EISSN: 1756-1833 ;DOI: 10.1136/bmj.n2943 ;PMID: 34845008

Full text available

8
Structural bases for the higher adherence to ACE2 conferred by the SARS‐CoV‐2 spike Q498Y substitution
Material Type:
Article
Add to My Research

Structural bases for the higher adherence to ACE2 conferred by the SARS‐CoV‐2 spike Q498Y substitution

Acta crystallographica. Section D, Biological crystallography., 2022-09, Vol.78 (9), p.1156-1170 [Peer Reviewed Journal]

2022 Elena Erausquin et al. published by IUCr Journals. ;2022. This article is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;Elena Erausquin et al. 2022 2022 ;ISSN: 2059-7983 ;ISSN: 0907-4449 ;EISSN: 2059-7983 ;EISSN: 1399-0047 ;DOI: 10.1107/S2059798322007677 ;PMID: 36048155

Full text available

9
Reduced sensitivity of SARS-CoV-2 variant Delta to antibody neutralization
Material Type:
Article
Add to My Research

Reduced sensitivity of SARS-CoV-2 variant Delta to antibody neutralization

Nature (London), 2021-08, Vol.596 (7871), p.276-280 [Peer Reviewed Journal]

COPYRIGHT 2021 Nature Publishing Group ;Copyright Nature Publishing Group Aug 12, 2021 ;Distributed under a Creative Commons Attribution 4.0 International License ;ISSN: 0028-0836 ;EISSN: 1476-4687 ;DOI: 10.1038/s41586-021-03777-9 ;PMID: 34237773

Full text available

10
BA.2.12.1, BA.4 and BA.5 escape antibodies elicited by Omicron infection
Material Type:
Article
Add to My Research

BA.2.12.1, BA.4 and BA.5 escape antibodies elicited by Omicron infection

Nature (London), 2022-08, Vol.608 (7923), p.593-602 [Peer Reviewed Journal]

Copyright Nature Publishing Group Aug 18, 2022 ;The Author(s) 2022 ;ISSN: 0028-0836 ;EISSN: 1476-4687 ;DOI: 10.1038/s41586-022-04980-y ;PMID: 35714668

Full text available

11
Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine through 6 Months
Material Type:
Article
Add to My Research

Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine through 6 Months

New England Journal of Medicine, 2021-11, Vol.385 (19), p.1761-1773 [Peer Reviewed Journal]

Copyright © 2021 Massachusetts Medical Society. All rights reserved. ;COPYRIGHT 2021 Massachusetts Medical Society ;2021. Not withstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://www.nejm.org/about-nejm/permissions?query=footer ;Copyright © 2021 Massachusetts Medical Society. All rights reserved. 2021 Massachusetts Medical Society ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa2110345 ;PMID: 34525277

Digital Resources/Online E-Resources

12
MAKING SENSE OF CORONAVIRUS MUTATIONS
Material Type:
Article
Add to My Research

MAKING SENSE OF CORONAVIRUS MUTATIONS

Nature (London), 2020-09, Vol.585 (7824), p.174-177 [Peer Reviewed Journal]

Copyright Nature Publishing Group Sep 10, 2020 ;ISSN: 0028-0836 ;EISSN: 1476-4687 ;DOI: 10.1038/d41586-020-02544-6

Full text available

13
Rapid Decay of Anti–SARS-CoV-2 Antibodies in Persons with Mild Covid-19
Material Type:
Article
Add to My Research

Rapid Decay of Anti–SARS-CoV-2 Antibodies in Persons with Mild Covid-19

The New England journal of medicine, 2020-09, Vol.383 (11), p.1085-1087 [Peer Reviewed Journal]

Copyright © 2020 Massachusetts Medical Society. All rights reserved. ;Copyright © 2020 Massachusetts Medical Society. All rights reserved. 2020 Massachusetts Medical Society ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMc2025179 ;PMID: 32706954

Full text available

14
Engineering defensin α‐helix to produce high‐affinity SARS‐CoV‐2 spike protein binding ligands
Material Type:
Article
Add to My Research

Engineering defensin α‐helix to produce high‐affinity SARS‐CoV‐2 spike protein binding ligands

Protein science, 2022-06, Vol.31 (6), p.e4355-n/a [Peer Reviewed Journal]

2022 The Protein Society. ;2022 The Protein Society ;ISSN: 0961-8368 ;EISSN: 1469-896X ;DOI: 10.1002/pro.4355 ;PMID: 35634778

Full text available

15
Risk of mortality in patients infected with SARS-CoV-2 variant of concern 202012/1: matched cohort study
Material Type:
Article
Add to My Research

Risk of mortality in patients infected with SARS-CoV-2 variant of concern 202012/1: matched cohort study

BMJ (Online), 2021-03, Vol.372, p.n579-n579 [Peer Reviewed Journal]

Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY. No commercial re-use. See rights and permissions. Published by BMJ. ;Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY. No commercial re-use. See rights and permissions. Published by BMJ. ;2021 Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY. No commercial re-use. See rights and permissions. Published by BMJ. BMJ This is an Open Access article distributed in accordance with the terms of the Creative Commons Attribution (CC BY 4.0) license, which permits others to distribute, remix, adapt and build upon this work, for commercial use, provided the original work is properly cited. See: http://creativecommons.org/licenses/by/4.0/ . Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY. No commercial re-use. See rights and permissions. Published by BMJ. 2021 BMJ ;ISSN: 1756-1833 ;ISSN: 0959-8138 ;EISSN: 1756-1833 ;DOI: 10.1136/bmj.n579 ;PMID: 33687922

Full text available

16
Adjuvanting a subunit COVID-19 vaccine to induce protective immunity
Material Type:
Article
Add to My Research

Adjuvanting a subunit COVID-19 vaccine to induce protective immunity

Nature (London), 2021-06, Vol.594 (7862), p.253-258 [Peer Reviewed Journal]

COPYRIGHT 2021 Nature Publishing Group ;Copyright Nature Publishing Group Jun 10, 2021 ;ISSN: 0028-0836 ;EISSN: 1476-4687 ;DOI: 10.1038/s41586-021-03530-2 ;PMID: 33873199

Full text available

17
The spike glycoprotein of the new coronavirus 2019-nCoV contains a furin-like cleavage site absent in CoV of the same clade
Material Type:
Article
Add to My Research

The spike glycoprotein of the new coronavirus 2019-nCoV contains a furin-like cleavage site absent in CoV of the same clade

Antiviral research, 2020-04, Vol.176 [Peer Reviewed Journal]

Attribution - NonCommercial - NoDerivatives ;ISSN: 0166-3542 ;EISSN: 1872-9096 ;DOI: 10.1016/j.antiviral.2020.104742 ;PMID: 32057769

Digital Resources/Online E-Resources

18
Heavily mutated Omicron variant puts scientists on alert
Material Type:
Article
Add to My Research

Heavily mutated Omicron variant puts scientists on alert

Nature (London), 2021-12, Vol.600 (7887), p.21-21 [Peer Reviewed Journal]

Copyright Nature Publishing Group Dec 2, 2021 ;ISSN: 0028-0836 ;EISSN: 1476-4687 ;DOI: 10.1038/d41586-021-03552-w

Full text available

19
Efficacy of NVX-CoV2373 Covid-19 Vaccine against the B.1.351 Variant
Material Type:
Article
Add to My Research

Efficacy of NVX-CoV2373 Covid-19 Vaccine against the B.1.351 Variant

New England Journal of Medicine, 2021-05, Vol.384 (20), p.1899-1909 [Peer Reviewed Journal]

Copyright © 2021 Massachusetts Medical Society. All rights reserved. ;Copyright © 2021 Massachusetts Medical Society. ;COPYRIGHT 2021 Massachusetts Medical Society ;2021. Not withstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://www.nejm.org/about-nejm/permissions?query=footer ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa2103055 ;PMID: 33951374

Digital Resources/Online E-Resources

20
Thrombotic Thrombocytopenia after ChAdOx1 nCov-19 Vaccination
Material Type:
Article
Add to My Research

Thrombotic Thrombocytopenia after ChAdOx1 nCov-19 Vaccination

New England Journal of Medicine, 2021-06, Vol.384 (22), p.2092-2101 [Peer Reviewed Journal]

Copyright © 2021 Massachusetts Medical Society. All rights reserved. ;Copyright © 2021 Massachusetts Medical Society. ;COPYRIGHT 2021 Massachusetts Medical Society ;2021. Not withstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://www.nejm.org/about-nejm/permissions?query=footer ;Copyright © 2021 Massachusetts Medical Society. All rights reserved. 2021 Massachusetts Medical Society ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa2104840 ;PMID: 33835769

Digital Resources/Online E-Resources

Results 1 - 20 of 5,381  for All Library Resources

Results 1 2 3 4 5 next page

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Show only

  1. Peer-reviewed Journals (4,162)

Refine My Results

New Records 

  1. New From Last Week  (1)
  2. New From Last Month  (19)
  3. New From Last 3 Month  (110)
  4. More options open sub menu

Language 

  1. English  (5,362)
  2. Japanese  (574)
  3. Portuguese  (11)
  4. German  (10)
  5. French  (6)
  6. Norwegian  (6)
  7. Chinese  (6)
  8. Spanish  (5)
  9. Indonesian  (2)
  10. Persian  (2)
  11. Russian  (1)
  12. Korean  (1)
  13. More options open sub menu

Searching Remote Databases, Please Wait